thin-cap fibroatheroma (TCFA) neointima and calcified neointima were detected in 22 (43.1%), 19 (37.3%), and 5 (9.8%) patients. Neoatherosclerosis was more frequently observed in BMS (12/16, 75.0%) compared with DES (11/33, 33.3%) (p¼0.013). The percentage of frames with neoatherosclerosis in the stent segment was higher in BMS (60.56% [38.36, 77.86] vs. 18.18% [12.50, 39.13], respectively, p¼0.006). Maximum consecutive lipid neointima length was longer in BMS than in DES (5.5mm [3.0, 10.1] and 2.5mm [1.2, 4.5], p¼0.022). There was no significant difference in the minimum fibrous cap thickness (53.3mm [53.3, 60.0] and 50.0mm [45.5, 53.3], respectively, p¼0.152).
BACKGROUND Computational fluid dynamics allow virtual evaluation of coronary physiology and shear stress (SS) . Most studies hitherto assumed the vessel as a single conduit without accounting for the flow through side branches. Our aim was to develop a new approach to reconstruct coronary geometry that also computes outgoing flow through side branches in hemodynamic and biomechanical calculations, using fusion of optical coherence tomography (OCT) and 3-Dimensional (3D) angiography.
METHODS Twenty-one patients enrolled in the DOCTOR Fusion study underwent OCT and 3D-angiography of the target vessel (9 LAD, 2 LCX, 10 RCA). Coronary 3D reconstruction was performed by fusion of OCT and angiography, creating a true anatomical tree model (TM) including the side branches, and a traditional single-conduit model (SCM) disregarding the side branches. RESULTS Pd/Pa ratio was significantly higher in TMs than in SCMs (0.904 vs. 0.842, p < 0.0001). Agreement between TM and SCM in identifying patients with a Pd/Pa ratio 0.80 under basal flow conditions was only k ¼ 0.417 (p ¼ 0.019). Average SS was 4.64 Pascal lower in TMs than in SCMs (p < 0.0001), with marked differences in the point-per-point comparison, ranging from -60.71 to 7.47 Pascal.
CONCLUSIONS True anatomical TMs that take into account the flow through side branches are feasible for accurate hemodynamic and biomechanical calculations. Traditional SCMs underestimate Pd/Pa and are inaccurate for regional SS estimation. Implementation of TMs might improve the accuracy of SS and virtual fractional flow reserve calculations, thus improving the consistency of biomechanical studies. BACKGROUND In patients with vasospastic angina (VSA), transient local hemodynamic changes due to vasospasm can result in endothelial damage and thrombus formation. However, its incidence has not been well-defined yet. The aim of this study was to evaluate the incidence of thrombus and plaque characteristics at coronary spasm segments compared to non-spasm segments in patients with suspicious VSA using optical coherence tomography (OCT).
METHODS One hundred and thirty three patients with suspected VSA were included in this study. The ergonovine provocation test was performed in all patients for the diagnosis of VSA except patients with spontaneous spasm. All target lesions were analyzed by OCT.
RESULTS 77 spasm segments in 66 VSA patients were compared with 46 non-spasm segments in 30 non-VSA patients. Thrombus was seen more frequently at spasm segments compared to non-spasm segments CONCLUSIONS Compared to non-spasm segments, thrombus and plaque erosion were more common at spasm segments. These findings suggest the potential benefit and treatment role of antiplatelet therapy in VSA. BACKGROUND Several investigations revealed that daily glucose fluctuation has adverse effects on endothelial cells. Moreover, we reported that it may have an independent contributing factor on coronary plaque vulnerability. Little is known, however, about its impact on neointimal growth after stenting in coronary artery disease (CAD) patients. We aimed to investigate the impact of glucose fluctuation on neointimal growth following everolimus-eluting stent (EES) implantation.
METHODS This prospective study enrolled 70 consecutive CAD patients pretreated with adequate lipid-lowering therapy. 46 patients of them underwent 8-month follow-up optical coherence tomography after EES implantation. Glucose fluctuation, expressed as mean amplitude of glycemic excursion (MAGE) was determined by continuous glucose monitoring before percutaneous coronary intervention. Uniformity of neointimal distribution was evaluated in 3-D by computing mean neointimal thickness (NIT) within 360 equally spaced radial sectors for every 1-mm cross-section by OCT analysis 8 months after stenting. In addition, we analyzed % of uncovered struts at OCT follow-up. No changes were made to any of the medications for the control of diabetes, lipids, and hypertension.
RESULTS
In total, 56 stents were evaluated in 46 patients. MAGE was significantly correlated with maximum NIT and standard deviation of NIT, representing the roughness of neointima within a whole stent (Figure) . Moreover, higher MAGE was significantly associated with the higher percentage of uncovered struts (Figure) . Multiple linear regression analysis showed MAGE had independently association with % of uncovered struts and standard deviation of NIT (standardized coefficient b ¼ 0.566 and 0.381, respectively, both P < 0.005).
CONCLUSIONS Glucose fluctuation may impact the vessel healing after EES implantation in CAD patients receiving adequate lipidlowering therapy. Further investigations should address the rationale for the early detection and control of glucose fluctuation in the era of universal statin use for CAD patients.
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